On the fly News and insights, exclusive to thefly.com

2021-02-26 09:54:23 FATE Fate Therapeutics $91.35 / +5.245 (+6.09%) , CALT Calliditas Therapeutics $29.73 / +1.42 (+5.02%) … 09:54 02/26/21 02/26 09:54 02/26/21 09:54	Fly Intel: Top five analyst initiations Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Fate Therapeutics (FATE) initiated with a Buy at BofA. 2. Calliditas Therapeutics (CALT) initiated with a Buy at H.C. Wainwright. 3. Personalis (PSNL) assumed with a Buy at Needham. 4. Trxade Group (MEDS) initiated with a Buy at Maxim. 5. Amyris (AMRS) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. FATE Fate Therapeutics $91.35 / +5.245 (+6.09%) CALT Calliditas Therapeutics $29.73 / +1.42 (+5.02%) PSNL Personalis $30.99 / -0.705 (-2.22%) MEDS Trxade Health $6.33 / -0.07 (-1.09%) AMRS Amyris $14.92 / +1.05 (+7.57%)	01 Mar 02 Mar 10 Mar 15 Mar 05 Jun 09 Jun 12 Aug 06 Jan 27 Jan 29 Jan

2021-02-26 09:54:23

FATE

Fate Therapeutics

$91.35 / +5.245 (+6.09%)

, CALT

Calliditas Therapeutics

$29.73 / +1.42 (+5.02%)

… 09:54

02/26/21

02/26

09:54

02/26/21

09:54

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Fate Therapeutics (FATE) initiated with a Buy at BofA. 2. Calliditas Therapeutics (CALT) initiated with a Buy at H.C. Wainwright. 3. Personalis (PSNL) assumed with a Buy at Needham. 4. Trxade Group (MEDS) initiated with a Buy at Maxim. 5. Amyris (AMRS) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

FATE

Fate Therapeutics